NCT05902286

Brief Summary

Older adults will be randomly assigned to an active heart rate variability biofeedback condition and a "sham" control condition. Stress recovery measures and emotional and cognitive functioning will be assessed before and following the five-week intervention to assess potential changes from the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 17, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 2, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 13, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2024

Completed
Last Updated

August 12, 2024

Status Verified

August 1, 2024

Enrollment Period

1.3 years

First QC Date

April 2, 2023

Last Update Submit

August 9, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Stress Recovery Change Following Intervention

    The first primary aim of the paper is to test whether there will be difference resting HRV measurements pre- to post-intervention.

    Through study completion, an average of 7 weeks.

  • Resting HRV Change Following Intervention

    The second primary aim of the study will be to test the utility of HRVB compared to sham control in improving HRV following a stressor in older adults using a randomized trial design.

    Through study completion, an average of 7 weeks.

Secondary Outcomes (5)

  • Emotional Functioning: Satisfaction with Life Scale

    Through study completion, an average of 7 weeks.

  • Emotional Functioning: Scale of Positive and Negative Emotions

    Through study completion, an average of 7 weeks.

  • Emotional Functioning: Geriatric Depression Scale-15

    Through study completion, an average of 7 weeks.

  • Emotional Functioning: Depression and Stress Anxiety Scale

    Through study completion, an average of 7 weeks.

  • Cognitive Functioning

    Through study completion, an average of 7 weeks.

Study Arms (2)

OSC+

EXPERIMENTAL

The 25 participants assigned to the OSC+ condition will complete a five-week intervention for the Osc+ portion of the study using emWave software for biofeedback. There will be one 30-60 minute in-person HRVB session once a week completed at the University Parkway Center. In addition to the in-person session, the participant will complete four 20-minute homework sessions during the following week. The format of five weeks of one weekly session and four homework sessions is effective at helping participants learn and implement breathing and biofeedback skills. The five HRVB session will be based on the Lehrer and colleagues' protocol.

Behavioral: OSC+

OSC-

SHAM COMPARATOR

Similarly, for the Osc- procedures, the client will be required to complete a five-week intervention. Participants will be instructed that the purpose of this portion of the study is to decrease their breathing oscillations. A program was designed by Yoo and colleagues that gives feedback regarding a "calmness" score which reflects a better score (i.e., higher) when participants breathe in a pattern that elicits less variability (i.e., less oscillations). They will be asked to complete four 20-minute homework assignments at home and asked to come up with techniques to decrease their heart rate.

Behavioral: OSC-

Interventions

OSC-BEHAVIORAL

During the first week, the baseline will be assessed and resonance frequency. Specifically, during their first intervention session the participants will be told that the goal of the sessions includes decreasing heart rate variability and avoiding slow and steady breathing. The participants will then be asked to choose five strategies to lower their heart rate oscillations. Participants will be told to avoid slow breathing as it causes large heart rate oscillations. For the second session, the therapist will check in with the participant and discuss how the practice went. Participants will then select three strategies that they will practice for three five-minute conditions following a five-minute baseline. Sessions three, four, and five will include three conditions: a five-minute baseline and two strategies of their choice. For each session, the best strategy will be calculated and written on the assignment sheets to be used during the week for their four homework sessions.

OSC-

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Fluent English speaker
  • Able to provide informed consent
  • years or Older

You may not qualify if:

  • Symptoms within the last year of a neurological disorder (e.g., dementia, stroke, epilepsy, traumatic brain injury with loss of consciousness in the last year, etc.).
  • Conditions that might affect the biofeedback training (i.e., pacemakers, previous self-reported heart attack with hospitalization, self-reported coronary artery disease)
  • Currently engaged in or have been previously trained in heart rate variability biofeedback.
  • or higher on the IQCODE.
  • Currently prescribed and taking beta-blockers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham Young Unversity

Provo, Utah, 84604, United States

Location

Study Officials

  • Michael J Larson, Ph.D.

    Brigham Young University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The testing sessions will be completed by research assistants who are blinded to the participant's condition as not to influence testing results. All participants will be randomized into a condition (e.g., Osc+ or Osc-) by a graduate student so research assistants doing the assessments are blinded to condition.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The investigators plan to collect a sample of 50 older adult participants (25 per group) for the current study. Participants who meet the inclusion and exclusion criteria will then be randomized into the Osc+ or Osc- group for the five-week condition. All randomization in this study will be completed using a quasi-random number generator constrained so there are equal numbers of participants in each condition.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 2, 2023

First Posted

June 13, 2023

Study Start

February 17, 2023

Primary Completion

May 22, 2024

Study Completion

May 22, 2024

Last Updated

August 12, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

Study protocol, materials, and analysis plans are already posted on the Open Science Framework (https://osf.io/vse5n). Actual study data (de-identified) will be made available, along with analysis codes, once the study has been complete and published.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Once data collection and data analysis has been completed and published in a scientific journal, the study data (de-identified) will either be posted on an open science website, such as the Open Science Framework, or will be given to other researchers upon request.
More information

Locations